D-0138-2018 Class II Terminated
FDA drug recall D-0138-2018 was initiated by SSM Health Care St. Louis DBA SSM St. Clare Health Center on August 10, 2017 and is designated Class II. Reason for recall: Lack of sterility assurance: Microbial growth detected during a routine simulation of the manufacturing process. No batches of distributed product have been identified as actually containing microorga… The recall status is terminated (terminated March 22, 2018). Affected quantity: N/A.
Recall Details
- Product Type
- Drugs
- Report Date
- January 3, 2018
- Initiation Date
- August 10, 2017
- Termination Date
- March 22, 2018
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- N/A
Product Description
Fentanyl 2 mcg/mL and ropivacaine 0.2% in 0.9% Sodium Chloride 150 mL, 150 mL bag, This is a compounded injectable drug; Rx only; Hospital/office use only. SSM St. Clare Outsourcing Facility, Fenton, MO. --- NDC: 88883-4272-01
Reason for Recall
Lack of sterility assurance: Microbial growth detected during a routine simulation of the manufacturing process. No batches of distributed product have been identified as actually containing microorganisms.
Distribution Pattern
SSM Health entities in the state of MO only
Code Information
Lot, exp: 170621-008, 09/19/2017; 170703-002, 10/01/2017; 170711-031, 10/09/2017